Roche signs definitive share purchase agreement with long-term partner TIB.
The Pharma Data
SEPTEMBER 8, 2021
The acquisition enables Roche to further expand the portfolio of currently over 45 CE-IVD assays and more than 100 research use assays on Roche`s LightCycler PCR instruments. TIB Molbiol is a biotech company that has supplied the global market with reagents for research and medical diagnostics for over 30 years.
Let's personalize your content